Currently, Charles River Laboratories International Inc [CRL] is trading at $174.95, down -1.34%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CRL shares have gain 19.02% over the last week, with a monthly amount glided 6.68%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Charles River Laboratories International Inc [NYSE: CRL] stock has seen the most recent analyst activity on October 06, 2025, when William Blair upgraded its rating to a Outperform. Previously, Barclays upgraded its rating to Overweight on October 02, 2025, and kept the price target unchanged to $195. On September 09, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $195 on the stock. Citigroup upgraded its rating to a Buy but stick to its price target of $200 on July 09, 2025. Redburn Atlantic upgraded its rating to a Buy but $182 remained the price target by the analyst firm on May 23, 2025. TD Cowen upgraded its rating to Buy for this stock on May 14, 2025, but kept the price target unchanged to $179. In a note dated May 08, 2025, Evercore ISI upgraded an Outperform rating on this stock but restated the target price of $170.
This stock has fluctuated between a low of $91.86 and a high of $230.02 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $196.67 within the next 12 months. Charles River Laboratories International Inc [NYSE: CRL] shares were valued at $174.95 at the most recent close of the market. An investor can expect a potential return of 12.41% based on the average CRL price forecast.
Analyzing the CRL fundamentals
Trailing Twelve Months sales for Charles River Laboratories International Inc [NYSE:CRL] were 4.03B which represents 0.59% growth. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at -0.0%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.02 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.83.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 173.26 points at the first support level, and at 171.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 178.14, and for the 2nd resistance point, it is at 181.33.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Charles River Laboratories International Inc [NYSE:CRL] is 1.36. Also, the Quick Ratio is 1.10, while the Cash Ratio stands at 0.17. Considering the valuation of this stock, the price to sales ratio is 2.14, the price to book ratio is 2.57.
Transactions by insiders
Recent insider trading involved Joseph LaPlume, Officer, that happened on Aug 22 ’25 when 400.0 shares were purchased. EVP, Corp Strategy & Develop, LaPlume Joseph W completed a deal on Aug 18 ’25 to sell 800.0 shares. Meanwhile, Former Director WALLMAN RICHARD F bought 22500.0 shares on Aug 18 ’25.
